Detailed Narrative
Strong Q1 Bookings and Advanced AI Revenue Growth
HCLTech reported its highest ever Q1 net new TCV bookings at $2.4 billion, indicating robust demand. The company's advanced AI revenue demonstrated significant growth, reaching $171 million, up 10.6% QoQ and 62.1% YoY. This performance underscores the company's focus on AI-led offerings and its intent to capitalize on AI-related market opportunities.
Operating Margin Expansion Despite Seasonal Weakness
Despite Q1 being a seasonally weaker quarter, HCLTech delivered a strong all-round performance with operating margins at 16.9%. This represents an improvement of 39 basis points QoQ and 56 basis points YoY. The margin expansion was supported by lower restructuring expenses (70 bps) and benefit on PDD (20 bps), partially offset by seasonality and decline in ERS revenue.
Strategic Investment in AI Datacenter Infrastructure
HCLTech announced a strategic initiative to enter the AI datacenter business in India, planning an initial investment of up to INR3,500 crores with potential to scale to 50 megawatts. This move aims to address the growing demand for AI-ready solutions and sovereign data requirements, positioning HCLTech as a key enabler of India's AI ecosystem. The investment will be phased and funded through a mix of internal accruals, partner arrangements, and committed client consumption.
AI Strategy and Ecosystem Momentum
The company's AI strategy, anchored on five pillars, showed significant progress. AI Force is now deployed across 92 client accounts, and advanced AI revenue grew 62.1% YoY. HCLTech also made a strategic investment of $150 million in Sarvam, an Indian full-stack sovereign AI company, and expanded partnerships with Google Cloud and OpenAI. These initiatives aim to build differentiated IP and scale AI-led services.
Vertical Performance and Headwinds
While IT and Business Services grew 4.2% YoY and remained flat sequentially, the Engineering and R&D Services (ERS) segment declined 3.7% QoQ and grew only 0.3% YoY. This was attributed to sharp cuts in discretionary spending by two large US telcos. The Healthcare segment also faced stress in the US market, contributing to a gradual decline over the past eight to nine quarters.
FY27 Guidance Maintained
HCLTech reiterated its FY27 revenue growth guidance of 1% to 4% in constant currency and EBIT margin guidance of 17.5% to 18.5%. Management noted that the mega deal signed in early July would have negligible impact on FY27 revenue, as its steady state is expected by April 2027. The guidance is organic and does not include acquisitions like Jaspersoft.